1 Min Read
March 20 (Reuters) - Gilead Sciences Inc :
* EPCLUSA, to treat all six genotypes of chronic Hepatitis C infection, added to Liste des médicaments de la RAMQ Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.